Results 131 to 140 of about 565,186 (153)
Some of the next articles are maybe not open access.
Unusual case of thiamine responsive megaloblastic anemia.
La Tunisie medicale, 2009Thiamine-responsive megaloblastic anemia syndrome is a rare autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and neurosensoriel deafness, responding in varying degrees to thiamine treatment.Report an unusual case of this rare disorderWe report the case of a four-year-old boy who presented unusual ...
Faten, Tinsa +5 more
openaire +1 more source
Thiamine responsive megaloblastic anemia: the puzzling phenotype.
Pediatric blood & cancer, 2014Thiamine responsive megaloblastic anemia (TRMA) is characterized by a triad of megaloblastic anemia, non-type 1 diabetes mellitus and sensorineural deafness. Other clinical findings have been described in few cases. The SLC19A2 gene on chromosome 1q 23.3 is implicated in all cases with TRMA.
Ismail, Beshlawi +5 more
openaire +1 more source
Thiamine-Responsive Megaloblastic Anemia Syndrome: A Disorder of High-Affinity Thiamine Transport
Blood Cells, Molecules, and Diseases, 2001Thiamine-responsive megaloblastic anemia (TRMA) syndrome (OMIM No. 249270) comprises a distinctive triad of clinical features: megaloblastic anemia with ringed sideroblasts, diabetes mellitus, and progressive sensorineural deafness. The TRMA gene has been mapped and cloned.
E J, Neufeld +3 more
openaire +2 more sources
Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.
Genetic counseling (Geneva, Switzerland), 2012The thiamine-responsive megaloblastic anemia syndrome (TRMA) is an autosomal recessive disorder characterized by diabetes mellitus, megaloblastic anemia and sensorineural hearing loss due to mutations in SLC 19A2 that encodes a thiamine transporter protein.
S, Yilmaz Agladioglu +4 more
openaire +1 more source
Thiamine-responsive megaloblastic anemia syndrome with dysrhythmia
Endocrine Abstracts, 2020Ebrashy Ibrahim El +5 more
openaire +1 more source
[Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
La Revue de medecine interne, 2019Thiamine-responsive megaloblastic anemia (TRMA), also known as Rogers syndrome, is a rare autosomal recessive disease characterized by three main components: megaloblastic anemia, diabetes mellitus and sensorineural deafness. Those features occur in infancy but may arise during adolescence. Diagnosis relies on uncovering genetic variations (alleles) in
Lu H +5 more
openaire +2 more sources
Cone-Rod Dystrophy in Thiamine-Responsive Megaloblastic Anemia
Journal of Pediatric Ophthalmology & Strabismus, 2003A, Kipioti +3 more
openaire +2 more sources
Effect of management of thiamine responsive megaloblastic anemia syndrome with sulbutiamine
2017Introduction: thiamine responsive megaloblastic anemia syndrome (TRMAS) is a rare autosomal recessive metabolic disorder. Management of TRMAS focuses on lifelong use of pharmacologic doses of thiamine (Th). High-dose Th may ameliorate diabetes, anemia and, conjecture, hearing defect if started from birth or prenatally.
Mikštienė, Violeta +7 more
openaire +1 more source
Thiamine-Responsive Megaloblastic Anemia Syndrome
2003Kimihiko Oishi, George Diaz, Bruce Gelb
openaire +1 more source
Thiamine responsive megaloblastic anemia: The puzzling phenotype
Pediatric Blood & Cancer, 2013Ismail Beshlawi +5 more
openaire +1 more source

